Summary
Overview
Work History
Education
Skills
Certification
Timeline
Generic

Staci Wasco

Westfield,NJ

Summary

Pfizer colleague with eight years of progressive Finance leadership and eleven years of Project Management experience. Extensive institutional knowledge, successful at leading matrix teams and devising strategic plans for complex customer requirements. Expertise with operating plans, product launches, and strategic analysis. Highly motivated and efficient at making decisions in high-pressure settings utilizing analytical problem-solving skills.

Overview

19
19
years of professional experience
1
1
Certification

Work History

Director, I&I Biopharma Finance

Pfizer, Inc.
New York, NY
08.2022 - Current
  • Manage budgeting, forecasting and Operating Plan across three Brands, including a $3B+ Gross Sales product and two complex 2023 Product Launches
  • Critical partner supporting strategy for all key launch activities for two launch Brands (launch pricing and market access strategy,
  • Plan and support strategies to grow revenue and leverage the P&L efficiently
  • 2023 I&I Premier Award Winner

Director, Transformation & Project Management

Pfizer, Inc.
New York, NY
11.2011 - 07.2022

Drive transformation and deliver value through flawless execution with an agile growth mindset.

Transformation and Continuous Improvement:

  • Tampa EF Hub PM Lead (2020- 2022): Drove Day 1 Operational Readiness plans cross-functionally to ensure a successful integration of ~500 colleagues by 2025 (HC upon leaving role was ~350).
  • Pfizer Global Recoveries Program PM Lead (2017- 2022: Facilitated financial recoveries across Pfizer, including $307M in recovery contributions between 2017 – 2022. Provide key updates to PGRP Steering Committee and Drive for Cash initiative to CFO.
  • Third Party Risk Management PM Lead (2020- 2021): Optimized the TPRM project team to provide a holistic approach to risk assessment and management across Pfizer's operations through governance, policy, process, and system capabilities. Drove key updates for to S&ES leaders.
  • 340B Duplicate Discount Assessment Lead (2019 - 2020): Directed a cross-functional Working Group to identify and prevent $11M in duplicate upfront 340B Medicaid payments while providing process improvement. Influenced key senior stakeholders to fund the ongoing duplicate discount solution and digital enablement.
  • Financial Reporting Initiative SUN Implementation Lead (2014 – 2015): Deployed strategy and execution to enable Balance Sheet Reporting business unit segmentation across 52 unique SUN instances.
  • Cross-Program Lead (2011 – 2013): Facilitated portfolio strategy an FPMO LT member with responsibility for two direct reports; coordinated prioritizing and identifying risks and interdependencies across Finance, including providing updates to the CFO.

Digital Technology:

  • Project Lighthouse PM Lead (2017 - 2018): Influenced strategy and orchestrated coordination for the first internal finance predictive analytics forecasting solution. Solution automated a Gross Sales to Margin SKU-level modeling and trending capability. Results included automating a previous manual forecasting tool while introducing a Brand-level trending automation to optimize LE and Op Plan submissions. Elicited Change Management support from key stakeholders in a challenging environment.
  • Digital Finance Transformation PMO (2017 - 2018): Coordinated the digital finance strategy across finance functions to identify, evaluate, and prioritize artificial intelligence and other innovative digital tool solutions.

Merger, Acquisition, and Divestiture:

  • Medivation Acquisition Finance Deputy PM Lead (2016 - 2017): Enabled global cross-Finance integration planning for the $14B Astellas / Xtandi transaction in a condensed timeframe.
  • Nutrition Divestiture Transaction Service Agreement Lead (2012 – 2013): Directed divestiture across 48 markets for the $12B transaction, including acting as lead negotiator for the Transaction Service Agreement. Managed TSA negotiations for two follow-on divestitures to separate Buyers
  • Zoetis Commercial Finance Preparedness Lead (2012 - 2013): Optimized Day 1 Spin-off planning activities across 19 Commercial Finance markets.

Secondment Global Market Access & Global Pricing

Pfizer, Inc.
New York, NY
07.2021 - 05.2022
  • Advanced US GPM Launch efforts, including co-leading Change Management and Training efforts
  • Launched GPM US State Price Transparency Model alongside Model N, delivering a first-in class digital platform
  • Demonstrated expertise in pricing governance requirements

Secondment Vaccines Integration Lead

Pfizer, Inc.
New York, NY
07.2015 - 01.2017
  • Mobilized 78 Commercial Finance Teams to integrate Seller's systems and processes into Pfizer operations
  • Provided critical updates to the Vaccine Leadership
  • Coordinated with Commercial Leads to prepare for local distribution of the newly integrated products
  • Acted as the key financial contact with Seller around operationalization of the Net Economic Benefit model
  • Assisted negotiations on key contracts between Buyer and Seller

Secondment, Decision Support Center of Excellence North America Lead

Pfizer, Inc.
New York, NY
11.2010 - 11.2011
  • Managed the North America DS CoE strategy, enabling the stand-up of a new organization with 47 colleagues to centralize standard management reporting capabilities across business units
  • Integrated a common global COE strategy alongside the European DS CoE
  • Consolidated 1,000+ diverse global management reports into 58 standardized reports

Finance Manager, Pfizer Animal Health

Pfizer, Inc.
New York, NY
11.2007 - 11.2010
  • Promoted from Senior Finance Analyst to Finance Manager in 2010
  • Coordinated and presented 2009-2011 Strategic Operating Plans for Equine and Shared Service P&L
  • Monitored and contributed to rebate pricing schemes for Equine Business
  • Influenced US Equine Op Plan Strategies; consolidated and monitored US Shared Service P&L

Internal Audit Supervisor

Pfizer, Inc.
New York, NY
04.2005 - 11.2007
  • Promoted to Audit Supervisor in October 2006
  • Managed field teams for global Internal Audits, including SOX-404 and Foreign Corrupt Practices Act

Education

Bachelor of Science - Accounting

The Pennsylvania State University

Skills

  • Operating Plan, Budgeting and Forecasting
  • 2023 Inflammation & Immunology Award Winner
  • Launch Product Experience
  • Innovative and collaborative thinker

Certification

  • Completed Pfizer Cornerstones of Management 2A - 2C and Digital Academy Bronze Generalist Badge
  • Six Sigma Yellow Belt Certified
  • 2014 and 2015 Boston Marathon Qualifier

Timeline

Director, I&I Biopharma Finance

Pfizer, Inc.
08.2022 - Current

Secondment Global Market Access & Global Pricing

Pfizer, Inc.
07.2021 - 05.2022

Secondment Vaccines Integration Lead

Pfizer, Inc.
07.2015 - 01.2017

Director, Transformation & Project Management

Pfizer, Inc.
11.2011 - 07.2022

Secondment, Decision Support Center of Excellence North America Lead

Pfizer, Inc.
11.2010 - 11.2011

Finance Manager, Pfizer Animal Health

Pfizer, Inc.
11.2007 - 11.2010

Internal Audit Supervisor

Pfizer, Inc.
04.2005 - 11.2007

Bachelor of Science - Accounting

The Pennsylvania State University
Staci Wasco